000			01678 a2200481 4500
005			20250517060837.0
264		0	_c20160623
008			201606s 0 0 eng d
022			_a1365-2249
024	7		_a10.1111/cei.12735 _2doi
040			_aNLM _beng _cNLM
100	1		_aBellemore, S M
245	0	0	_aPathogenic T helper type 17 cells contribute to type 1 diabetes independently of interleukin-22. _h[electronic resource]
260			_bClinical and experimental immunology _cMar 2016
300			_a380-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdoptive Transfer
650	0	4	_aAnimals
650	0	4	_aAntibodies, Blocking _ximmunology
650	0	4	_aAntibodies, Neutralizing _ximmunology
650	0	4	_aAutoimmunity
650	0	4	_aCell Differentiation
650	0	4	_aDiabetes Mellitus, Type 1 _ximmunology
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aInterferon-gamma _ximmunology
650	0	4	_aInterleukin-27 _ximmunology
650	0	4	_aInterleukins _xbiosynthesis
650	0	4	_aIslets of Langerhans _xmetabolism
650	0	4	_aMice, Inbred NOD
650	0	4	_aPancreas _ximmunology
650	0	4	_aReceptors, Interleukin _xmetabolism
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aTh17 Cells _ximmunology
650	0	4	_aInterleukin-22
700	1		_aNikoopour, E
700	1		_aKrougly, O
700	1		_aLee-Chan, E
700	1		_aFouser, L A
700	1		_aSingh, B
773	0		_tClinical and experimental immunology _gvol. 183 _gno. 3 _gp. 380-8
856	4	0	_uhttps://doi.org/10.1111/cei.12735 _zAvailable from publisher's website
999			_c25382581 _d25382581